Skip to content

Quo-Test A1c System

by EKF-diagnostic GmbH

510(k) K180509

Quo-Test A1c System is a medical device (FDA Class II; FDA product code LCP, Assay, Glycosylated Hemoglobin) made by EKF-diagnostic GmbH, cleared under FDA 510(k) K180509 on 16 Feb 2019, active as of 22 Oct 2026.

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Source FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Dual Track NumberK180509 Date16 Feb 2019ClearedStatusActive

Official records

From the FDA record

Received by the FDA
27 Feb 2018
FDA decision
16 Feb 2019 (Substantially Equivalent)
FDA review time
354 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K180509 (openFDA), as read on 22 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
LCP
Device class
Class II
Regulation
21 CFR Part 864.7470
Advisory committee
Hematology
FDA decision
SESE Substantially Equivalent

Similar devices

Other devices filed under FDA product code LCP (Assay, Glycosylated Hemoglobin).

Other devices from EKF-diagnostic GmbH

See all devices from EKF-diagnostic GmbH →